Cargando...
Conditioning neoadjuvant therapies for improved immunotherapy of cancer
Recent advances in the treatment of melanoma and non-small cell lung cancer (NSCLC) by combining conventional therapies with anti-PD1/PD-L1 immunotherapies, have renewed interests in immunotherapy of cancer. The emerging concept of conventional cancer therapies combined with immunotherapy differs fr...
Gardado en:
| Publicado en: | Biochem Pharmacol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5681417/ https://ncbi.nlm.nih.gov/pubmed/28803721 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2017.08.007 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|